Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8440904 | European Journal of Cancer | 2016 | 9 Pages |
Abstract
This is the first study to compare the effects of Met to Fen in cancer patients with a neuropathic pain component. Based on the results of this study, Met should be considered in the treatment of oncological pain with a neuropathic component.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
J. Haumann, J.W. Geurts, S.M.J. van Kuijk, B. Kremer, E.A. Joosten, M.H.J. van den Beuken-van Everdingen,